Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Governor Rell: State Of Connecticut To Receive $3.75 Million Grant To Enhance Heath Care Access For At-Risk Mothers
Governor M. Jodi Rell announced that the State of Connecticut is receiving $3.75 million federal grant to expand access to health care in Hartford for low-income women nearing childbirth to ensure their newborns get a healthy start.
generic viagra online
Swine Flu: NIAID Set To Launch Clinical Trials To Test 2009 H1N1 Influenza Vaccine Candidates
Scientists in a network of medical research institutions across the United States are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines. The research will be under the direction of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
News of the day
As Patients Age, Future Physicians Develop End Of Life Skills
The American Medical Student Association (AMSA), the nation"s oldest and largest, independent association for physicians-in-training, is pleased to present the graduates of the AMSA Foundation-VITAS End of Life Education Fellowship Program. Five medical students have spent the past six weeks immersing themselves in end of life (EOL) care issues.
Nutrition

The European Biotech Industry Applauds UK Efforts To Place Industrial Biotech At The Center Of A Low Carbon Economy

EuropaBio, the European biotech industry association applauds the report "IB 2025: Maximising UK Opportunities from Industrial Biotechnology in a Low Carbon Economy" (1) released today by the UK"s Department for Business Enterprise and Regulatory Reform (BERR). The biotech industry welcomes the report which is completely in line with the EU"s Lead Market Initiative for Biobased Products (2). EuropaBio is also pleased to note that the report also embraces EuropaBio"s policy recommendations (3) developed to help the EU realise the vision of a Knowledge-Based Bio-Economy (KBBE). "A competitive European Knowledge-based Bioeconomy can only be realised when the European Union and the member states put a coherent policy framework in place. What has been done in the UK will motivate industry to continue investment in this emerging and innovative industrial sector" said Dirk Carrez, EuropaBio"s Director, Industrial Biotechnology. Over the last two years the biotech industry has supported the European Commission to work out a set of concrete steps to realise the vision of a Knowledge-Based Bio-Economy (KBBE), where biotechnology"s new, clean, energy-efficient processes and innovative biobased products create a sustainable industrial base to ensure Europe"s future prosperity. EuropaBio"s "Industrial Biotechnology Policy Agenda for Europe" (3) produced an outline of policy recommendations to develop a competitive KBBE in Europe, but recognized that in order for these recommendations to be implemented, political support was needed. "EuropaBio is pleased to note the support these recommendations have received from the UK government" said Willy De Greef, EuropaBio"s Secretary General. "Developing an innovation driven economy is at the core of the Lisbon partnership. It is only with support of the member states that the vision to support growth and jobs in Europe by stimulating innovation can be realized." Notes (1) IB 2025: Maximising UK Opportunities from Industrial Biotechnology in a Low Carbon Economy See here. (2) The Commission Website on the Lead Market Initiative (3) Industrial Biotechnology Policy Agenda for Europe EuropaBio


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009